ArticleMolecular biology reports2025
Morin hydrate treatment minimizes Di(2-ethylhexyl) phthalate-induced uterine fibrosis, oxidative stress, and apoptosis in mice.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanistic insights and ameliorative strategies: advances in DEHP-induced metabolic toxicity and intervention by natural bioactive compounds and probiotics.Lipids in health and disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDi (2-ethylhexyl) phthalate (DEHP), a widely used chemical in plastics, has various health hazards when accumulated in the environment. DEHP has been shown to cause toxicity to various organs like the liver, kidney, and reproductive organs. Phytocompounds have been used to mitigate DEHP-mediated organ toxicity. Morin hydrate (MH), a phytocompound, has also been known to protect tissue and organs against various induced toxic conditions. However, the impact of MH treatment on DEHP-induced uterine dysfunction has not yet been still investigated. Therefore, the present study has investigated the impact of MH on uterine physiology and morphology of DEHP-intoxicated mice.
methodsTwenty Swiss mice were randomly divided into four groups (n = 5): control (CN), Di (2-ethylhexyl) phthalate (DP) (500 mg/kg), Di (2-ethylhexyl) phthalate (DP) + Morin hydrate (MH) (10 mg/kg), and Di (2-ethylhexyl) phthalate (DP) + Morin hydrate (MH) (100 mg/kg) for 14 days.
resultsOur results showed that the expression of active caspase-3 was up-regulated, and Bcl2 was down-regulated in the uterus of DEHP-treated mice. Furthermore, the uterine histology also showed decreased luminal epithelium height and endometrium thickness in the DEHP-treated mice; however, myometrium layer (outer and inner) thickness was higher in DEHP-treated mice. The uterus of DEHP-treated mice also exhibited elevated oxidative stress and fibrosis, along with decreased estrogen levels and expression of estrogen receptors (ERs). MH treatment at both doses (10 and 100 mg/kg) suppressed DEHP-induced uterine apoptosis (increased Bcl2 and decreased active caspase-3 expression) and fibrosis. MH also increased the circulating estrogen levels at both doses; Further ERα and ERβ expression were elevated in the MH treated in both groups). The levels of oxidative stress malondialdehyde (MDA levels) were higher in the uterus of DEHP alone and DEHP plus MH-treated mice (100 mg/kg). Moreover, the antioxidant enzymes catalase, glutathione peroxidase and superoxide dismutase (Gpx and SOD) did not show a dose-dependent response to MH treatment; rather, MH showed a differential effect on these enzymes. The elevated oxidative stress in 100 mg/kg MH treated uterus, despite elevated Gpx and SOD, remains unclear. Thus, these results suggest that MH ameliorates DEHP-induced uterine fibrosis, apoptosis, and histoarchitecture through ER modulation.
conclusionThese findings suggest that MH improves uterine structure and function in DEHP-treated mice.
Indexed as
Identifiers
40080243What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.